13 KEY THERAPEUTIC AREAS WITH OVER 55,000 PRODUCT ANALYZED13 KEY THERAPEUTIC AREAS WITH OVER 55,000 PRODUCT ANALYZED

&&

Extract from our 2008 CNS pipeline reportExtract from our 2008 CNS pipeline report

Pipeline Analysis Portfolio Pipeline Analysis Portfolio 20092009

For your considerationFor your consideration

Available across 13 therapeutic areas!Available across 13 therapeutic areas!

Therapeutic AreaTherapeutic Area No. ofNo. of pipelinespipelinesproducts products ReviewedReviewed

Ophthalmology Ophthalmology new!new!

Metabolic & Endocrinology (Diabetes) Metabolic & Endocrinology (Diabetes) new!new!

422422

847847

19651965

96289628

Autoimmune & Inflammation Autoimmune & Inflammation new!new! 10281028 42284228

CardiovascularCardiovascular 912912 62656265

CNSCNS 12301230 92209220

CancerCancer 11081108 70437043

Infectious DiseaseInfectious Disease 12001200 1084510845

GastrointestinalGastrointestinal 853853 43344334

DermatologyDermatology 792792 36203620

Respiratory CareRespiratory Care 829829 33473347

Women’s HealthWomen’s Health 462462 14641464

2008 CNS Pipeline report2008 CNS Pipeline reportOverview of 1230 companies in CNS area and breakdown of their pipeline by Overview of 1230 companies in CNS area and breakdown of their pipeline by

the developmental stage (from pre-clinical to market stage)the developmental stage (from pre-clinical to market stage)

CNS pipeline CNS pipeline product descriptionproduct description of 9200 products from 1230 companies (pre- of 9200 products from 1230 companies (pre-clinical to marketing status)clinical to marketing status)

(Company Name, Product, Description, Trial Details…(Company Name, Product, Description, Trial Details…

……and also…Phase, Indication, Diseasehubs, MOA, Drug Class information on and also…Phase, Indication, Diseasehubs, MOA, Drug Class information on over 9200 pipeline products reviewed…over 9200 pipeline products reviewed…

CNS pipeline pivot table - Breakdown of 1230 companies pipelines by their CNS pipeline pivot table - Breakdown of 1230 companies pipelines by their indication areas and development stages (PC-Market) indication areas and development stages (PC-Market)

(covering from smallest biotechs to largest pharma companies) (covering from smallest biotechs to largest pharma companies)

PivotChart of companies pipeline development, broken down by the indication PivotChart of companies pipeline development, broken down by the indication areaarea

(i.e. Wyeth CNS pipeline below)(i.e. Wyeth CNS pipeline below)

Overview of ALL compounds across the 1230 companies analyzed Overview of ALL compounds across the 1230 companies analyzed breakdown by an indication area and a development stage (i.e. Multiple breakdown by an indication area and a development stage (i.e. Multiple

Sclerosis Phase II – 40 products)… and …Sclerosis Phase II – 40 products)… and …

……those 40 products extracted, for quicker access, from a list of 9200 productsthose 40 products extracted, for quicker access, from a list of 9200 products

Overview of financial performance of 1230 companies analyzedOverview of financial performance of 1230 companies analyzed

Overview of Overview of KEY LICENSING DEALSKEY LICENSING DEALS in CNS sector – intel on Component, in CNS sector – intel on Component, Source, PartnersSource, Partners……

… … and also… Deal Type, Milestone in $mil, Deal Title and Deal Summaryand also… Deal Type, Milestone in $mil, Deal Title and Deal Summary

CNS dealsCNS deals (mergers, acquisitions, license, commercialization, development, (mergers, acquisitions, license, commercialization, development, marketing…) – intel on all companies analyzedmarketing…) – intel on all companies analyzed

New in 2009New in 2009! Contact info on KEY DECISION MAKERS within the companies ! Contact info on KEY DECISION MAKERS within the companies analyzedanalyzed

How Pipeline Databooks are How Pipeline Databooks are updatedupdated

Company websitesCompany websites SEC FilingsSEC Filings Capital IQCapital IQ United States Patent and Trademark Office, European United States Patent and Trademark Office, European

Patent Office and FDA’s Orange BookPatent Office and FDA’s Orange Book Company news, PR News Wire, Business Wire, and Company news, PR News Wire, Business Wire, and

Marketwatch, TheStreet.com, other news wires and Marketwatch, TheStreet.com, other news wires and servicesservices

Custom Spiders to track latest news, management bios, Custom Spiders to track latest news, management bios, and product changes on a daily basisand product changes on a daily basis

Abstracts from Pubmed and scientific meetingsAbstracts from Pubmed and scientific meetings Various commercial information sources such as Various commercial information sources such as

industry newsletters, analysts reports and online industry newsletters, analysts reports and online databasesdatabases

Trade publicationsTrade publications Company interviewsCompany interviews

For further information please contact…For further information please contact…

Daniel HealyDaniel Healy Business Development Director - HealthcareBusiness Development Director - Healthcare Business InsightsBusiness Insights

Tel: (+44) 207 675 7064Tel: (+44) 207 675 7064 dhealy@globalbusinessinsights.comdhealy@globalbusinessinsights.com